SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.190-0.8%Dec 24 12:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KMBJN. who wrote (12384)11/5/2019 4:00:22 PM
From: hpgrant  Read Replies (3) of 12873
 
Assume mfg cost is $100 a dose. Outcome is very different.

Point is: we don't know anything about cost, nor do we have much of an idea of price of a dose on the market. NNVC's bottom line can vary wildly with different assumptions.

No need to argue about the $100 a dose number - it's not a claim; it's used only to clarify the problem.

I have no idea what the cost per dose will be at any scale of production. It would be interesting to see some well founded estimates. Without those, we can't even begin to make accurate guesses about outcome for NNVC.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext